THE CLINICAL CHARACTERISTICS AND EFFICACY OF BISPHOSPHONATES IN AUDLT PATIENTS WITH OSTEOGENESIS IMPERGECTA.
作者： Xiao-jie Xu , Dou-dou Ma , Fang Lv , Jian-yi Wang , Yi Liu
DOI: 10.4158/EP151184.OR
关键词: Intravenous bisphosphonates 、 Internal medicine 、 Medicine 、 Bone Density Conservation Agents 、 Bone density 、 Bone remodeling 、 Osteogenesis imperfecta 、 Surgery 、 Randomized controlled trial 、 Zoledronic acid 、 Recurrent fractures
摘要: Objective: Osteogenesis imperfecta (OI) is characterized by low bone mass and recurrent fractures. Adults with OI are often treated oral or intravenous bisphosphonates (BPs). We investigated t...
aace.com 参考文章(38)
Zhiwei Ning, Shufan Song, Li Miao, Pengrui Zhang, Xin Wang, Jia Liu, Yanjin Hu, Yuan Xu, Tingting Zhao, Yufang Liang, Qingtao Wang, Lihong Liu, Jing Zhang, Lizhi Hu, Mingyan Huo, Qinyun Zhou, High prevalence of vitamin D deficiency in urban health checkup population Clinical Nutrition. ,vol. 35, pp. 859- 863 ,(2016) , 10.1016/J.CLNU.2015.05.019
Evelise Brizola, Jay Robert Shapiro, Bisphosphonate Treatment of Children and Adults with Osteogenesis Imperfecta: Unanswered Questions Calcified Tissue International. ,vol. 97, pp. 101- 103 ,(2015) , 10.1007/S00223-015-0021-6
Ester B.G. Rijks, Bart C. Bongers, Marloes J.G. Vlemmix, Annemieke M. Boot, Atty T.H. van Dijk, Ralph J.B. Sakkers, Marco van Brussel, Efficacy and Safety of Bisphosphonate Therapy in Children with Osteogenesis Imperfecta : A Systematic Review Hormone Research in Paediatrics. ,vol. 84, pp. 26- 42 ,(2015) , 10.1159/000381713
Telma Palomo, François Fassier, Jean Ouellet, Atsuko Sato, Kathleen Montpetit, Francis H Glorieux, Frank Rauch, Intravenous Bisphosphonate Therapy of Young Children With Osteogenesis Imperfecta: Skeletal Findings During Follow Up Throughout the Growing Years. Journal of Bone and Mineral Research. ,vol. 30, pp. 2150- 2157 ,(2015) , 10.1002/JBMR.2567
R. Kocijan, C. Muschitz, J. Haschka, D. Hans, A. Nia, A. Geroldinger, M. Ardelt, R. Wakolbinger, H. Resch, Bone structure assessed by HR-pQCT, TBS and DXL in adult patients with different types of osteogenesis imperfecta Osteoporosis International. ,vol. 26, pp. 2431- 2440 ,(2015) , 10.1007/S00198-015-3156-4
Kerry Dwan, Carrie A Phillipi, Robert D Steiner, Donald Basel, Bisphosphonate therapy for osteogenesis imperfecta. Cochrane Database of Systematic Reviews. ,vol. 10, pp. 0- 0 ,(2016) , 10.1002/14651858.CD005088.PUB4
Konstantinos N. Manolopoulos, Andrew West, Neil Gittoes, The paradox of prevention--bilateral atypical subtrochanteric fractures due to bisphosphonates in osteogenesis imperfecta. The Journal of Clinical Endocrinology and Metabolism. ,vol. 98, pp. 871- 872 ,(2013) , 10.1210/JC.2012-4195
S Adami, D Gatti, F Colapietro, E Fracassi, V Braga, M Rossini, L Tatò, Intravenous neridronate in adults with osteogenesis imperfecta. Journal of Bone and Mineral Research. ,vol. 18, pp. 126- 130 ,(2003) , 10.1359/JBMR.2003.18.1.126
Vania Braga, Davide Gatti, Maurizio Rossini, Francesca Colapietro, Elia Battaglia, Ombretta Viapiana, Silvano Adami, Bone turnover markers in patients with osteogenesis imperfecta. Bone. ,vol. 34, pp. 1013- 1016 ,(2004) , 10.1016/J.BONE.2004.02.023
Raphael P H Meier, Kuntheavy Ing Lorenzini, Brigitte Uebelhart, Richard Stern, Robin E Peter, René Rizzoli, Atypical femoral fracture following bisphosphonate treatment in a woman with osteogenesis imperfecta—a case report Acta Orthopaedica. ,vol. 83, pp. 548- 550 ,(2012) , 10.3109/17453674.2012.729183